ASXL3
Basic information
Region (hg38): 18:33578219-33751195
Previous symbols: [ "KIAA1713" ]
Links
Phenotypes
GenCC
Source:
- severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome (Definitive), mode of inheritance: AD
- severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome (Strong), mode of inheritance: AD
- severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome (Strong), mode of inheritance: AD
- severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome (Supportive), mode of inheritance: AD
- syndromic intellectual disability (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Bainbridge-Ropers syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Dermatologic; Musculoskeletal; Neurologic | 23383720 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (53 variants)
- Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome (50 variants)
- Inborn genetic diseases (11 variants)
- Neurodevelopmental disorder (2 variants)
- ASXL3-related disorder (1 variants)
- Gastrostomy tube feeding in infancy;Decreased activity of mitochondrial complex I;Global developmental delay;Absent speech;Generalized hypotonia (1 variants)
- Autism spectrum disorder (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASXL3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 59 | 16 | 81 | |||
missense | 190 | 105 | 19 | 315 | ||
nonsense | 30 | 28 | 60 | |||
start loss | 0 | |||||
frameshift | 60 | 34 | 100 | |||
inframe indel | 8 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 3 | 3 | ||||
non coding | 23 | 46 | 70 | |||
Total | 93 | 65 | 211 | 188 | 82 |
Variants in ASXL3
This is a list of pathogenic ClinVar variants found in the ASXL3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-33578269-C-A | Benign (Jan 13, 2019) | |||
18-33578458-CCCG-C | Benign (Aug 06, 2019) | |||
18-33578458-CCCGCCGCCG-C | Likely benign (Sep 23, 2019) | |||
18-33578458-C-CCCG | Benign (Sep 15, 2019) | |||
18-33578458-C-CCCGCCG | Likely benign (Oct 02, 2019) | |||
18-33578460-CGCCGCCGCCGCCG-C | Likely benign (Aug 26, 2019) | |||
18-33578640-CAA-C | Likely pathogenic (Jul 19, 2018) | |||
18-33578660-G-A | Inborn genetic diseases | Uncertain significance (Dec 06, 2021) | ||
18-33578666-G-C | Uncertain significance (Dec 12, 2023) | |||
18-33578667-G-A | Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome | Likely pathogenic (Dec 14, 2021) | ||
18-33578904-G-GCGTCCGGGAC | Likely benign (Nov 02, 2020) | |||
18-33578991-C-T | Benign (Aug 10, 2018) | |||
18-33607554-T-C | Benign (Mar 29, 2020) | |||
18-33607600-G-A | Uncertain significance (Oct 22, 2021) | |||
18-33607606-C-T | not specified | Uncertain significance (Mar 06, 2024) | ||
18-33607611-C-T | Uncertain significance (Apr 01, 2021) | |||
18-33607742-G-A | Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome | Benign (Dec 05, 2021) | ||
18-33607946-C-A | Benign (Jul 27, 2018) | |||
18-33607970-T-G | Likely benign (Aug 17, 2018) | |||
18-33616691-GAA-G | ASXL3-related disorder | Uncertain significance (Aug 09, 2023) | ||
18-33626925-A-G | Benign (Sep 01, 2022) | |||
18-33644557-TG-T | Likely benign (Jul 26, 2018) | |||
18-33644560-A-AC | Likely benign (Nov 14, 2019) | |||
18-33644925-A-G | Likely benign (Aug 01, 2024) | |||
18-33644949-G-A | Uncertain significance (Jan 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASXL3 | protein_coding | protein_coding | ENST00000269197 | 12 | 172578 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000156 | 124624 | 0 | 14 | 124638 | 0.0000562 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.607 | 1097 | 1.16e+3 | 0.950 | 0.0000588 | 14607 |
Missense in Polyphen | 296 | 369.71 | 0.80062 | 4842 | ||
Synonymous | -0.125 | 448 | 445 | 1.01 | 0.0000251 | 4534 |
Loss of Function | 7.02 | 8 | 72.6 | 0.110 | 0.00000386 | 993 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000937 | 0.0000936 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.0000929 | 0.0000928 |
European (Non-Finnish) | 0.0000635 | 0.0000619 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.0000659 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development. PcG proteins are not required to initiate repression, but to maintain it during later stages of development. They probably act via methylation of histones, rendering chromatin heritably changed in its expressibility (By similarity). {ECO:0000250}.;
Intolerance Scores
- loftool
- 0.222
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.87
Haploinsufficiency Scores
- pHI
- 0.108
- hipred
- Y
- hipred_score
- 0.553
- ghis
- 0.528
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.254
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asxl3
- Phenotype
Gene ontology
- Biological process
- transcription, DNA-templated;animal organ morphogenesis;positive regulation of transcription by RNA polymerase II
- Cellular component
- nuclear chromatin;nucleus;PR-DUB complex
- Molecular function
- DNA binding;chromatin binding;peroxisome proliferator activated receptor binding;metal ion binding